Haploinsufficiency for CHD7, an ATP-dependent nucleosome remodeling factor, is the leading cause of CHARGE syndrome. While congenital heart defects (CHDs) are major clinical features of CHARGE syndrome, affecting >75%of patients, itremains unclear whether CHD7 can directly regulate cardiogenic genesin embryos. Our complementary yeast two-hybrid and biochemical assays reveal that CHD7 is a novel interaction partner of canonical BMP signaling pathway nuclear mediators, SMAD1/5/8, in the embryonic heart. Moreover, CHD7 associates in a BMP-dependent manner with the enhancers of a critical cardiac transcription factor, Nkx2.5, that contain functional SMAD1-binding elements. Both the active epigenetic signature of Nkx2.5 regulatory elements and its proper expression in cardiomyocytes require CHD7. Finally, inactivation of Chd7 in mice impairs multiple BMP signaling-regulated cardiogenic processes. Our results thus support the model that CHD7 is recruited by SMAD1/5/8 to the enhancers of BMP-targeted cardiogenic genes to epigenetically regulate their expression. Impaired BMP activities in embryonic hearts may thus have amajor contribution to CHDs in CHARGE syndrome. © The Author 2013. Published by Oxford University Press. All rights reserved.
CITATION STYLE
Liu, Y., Harmelink, C., Peng, Y., Chen, Y., Wang, Q., & Jiao, K. (2014). CHD7 interacts with BMP R-SMADs to epigenetically regulate cardiogenesis in mice. Human Molecular Genetics, 23(8), 2145–2156. https://doi.org/10.1093/hmg/ddt610
Mendeley helps you to discover research relevant for your work.